The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
The pandemic has had significant impact to industries around the world and the Pharma Industry has been no exception. Early on, the Pharma Industry responded with unprecedented speed to bring treatments to patients through collaborations, leveraging expertise and creative solutions. Today, we continue to navigate the pandemic with resilience and continued partnership. This session covers a few of these collaborations and extraordinary responses COVID-19 Pandemic.
Session Leader(s):
Tara
Tibbs,
Sr Director Engineering API/DP,
Eli Lilly & Co